bioAffinity Technologies 宣布完成400万美元市价私募配售定价,符合纳斯达克规则

美股速递
Aug 13

bioAffinity Technologies, Inc. 今日正式对外宣布,其规模达400万美元的市价私募配售已成功完成定价。此次发行严格遵循纳斯达克市场规则,以现行市场价格进行交易。这是一次备受瞩目的资本运作,为公司未来发展注入了新的活力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10